Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Contingent Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹89 Cr₹48 Cr₹83 Cr₹35 Cr₹242 Cr

What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?

The latest Contingent Liabilities ratio of MANKIND PHARMA is ₹89 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹89 Cr
Mar2023₹48 Cr
Mar2022₹83 Cr
Mar2021₹35 Cr
Mar2020₹242 Cr

How is Contingent Liabilities of MANKIND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2024 ₹89 Cr
85.77
Mar2023 ₹48 Cr
-41.97
Mar2022 ₹83 Cr
137.32
Mar2021 ₹35 Cr
-85.60
Mar2020 ₹242 Cr -

Compare Contingent Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹103,524.9 Cr 0.6% 3.1% 34.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,271.0 Cr -0.9% -4.8% 50.2% Stock Analytics
DIVIS LABORATORIES ₹161,183.0 Cr 3% 5.9% 65% Stock Analytics
CIPLA ₹120,605.0 Cr 1.5% 0.1% 19.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,869.0 Cr -0.4% -8.2% 7.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,808.6 Cr 0.6% -5.3% 51% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.6%

3.1%

34.4%

SENSEX

3.5%

-0.1%

21.9%


You may also like the below Video Courses